ICOSAVAX, INC. General and Administrative Expense
ICOSAVAX, INC. reported General and Administrative Expense of $8.61 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2023-11-14
- ICOSAVAX, INC. general and administrative expense for the quarter ending 2023-09-30 was $8.61M, a 12.38% increase year-over-year.
- ICOSAVAX, INC. general and administrative expense for the quarter ending 2023-06-30 was $9.13M, a 24.87% increase year-over-year.
- ICOSAVAX, INC. general and administrative expense for the quarter ending 2023-03-31 was $9.16M, a 44.97% increase year-over-year.
- ICOSAVAX, INC. general and administrative expense for the quarter ending 2022-12-31 was $8.94M, a 43.74% increase year-over-year.
- ICOSAVAX, INC. general and administrative expense for fiscal 2022 was $30.23M, a 13.35% decline from fiscal 2021.
- ICOSAVAX, INC. general and administrative expense for fiscal 2021 was $34.89M, a 1212.03% increase from fiscal 2020.
- ICOSAVAX, INC. general and administrative expense for fiscal 2020 was $2.66M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $8.61M 10-Q · filed 2023-11-14 | $17.74M derived: sum of 2 quarters · filed 2023-11-14 | $26.90M 10-Q · filed 2023-11-14 | $35.84M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $9.13M 10-Q · filed 2023-08-14 | $18.29M 10-Q · filed 2023-08-14 | $27.23M derived: sum of 3 quarters · filed 2023-08-14 | $34.89M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | $9.16M 10-Q · filed 2023-05-10 | $18.10M derived: sum of 2 quarters · filed 2023-05-10 | $25.76M derived: sum of 3 quarters · filed 2023-11-14 | $33.07M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | $8.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $16.60M derived: sum of 2 quarters · filed 2023-11-14 | $23.91M derived: sum of 3 quarters · filed 2023-11-14 | $30.23M 10-K · filed 2023-03-30 |
| 2022-09-30 | $7.66M 10-Q · filed 2023-11-14 | $14.97M derived: sum of 2 quarters · filed 2023-11-14 | $21.29M 10-Q · filed 2023-11-14 | $27.51M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $7.31M 10-Q · filed 2023-08-14 | $13.63M 10-Q · filed 2023-08-14 | $19.85M derived: sum of 3 quarters · filed 2023-08-14 | $45.21M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $6.32M 10-Q · filed 2023-05-10 | $12.54M derived: sum of 2 quarters · filed 2023-05-10 | $37.90M derived: sum of 3 quarters · filed 2023-05-10 | $40.12M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $6.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $31.57M derived: sum of 2 quarters · filed 2023-03-30 | $33.80M derived: sum of 3 quarters · filed 2023-03-30 | $34.89M 10-K · filed 2023-03-30 |
| 2021-09-30 | $25.36M 10-Q · filed 2022-11-14 | $27.58M derived: sum of 2 quarters · filed 2022-11-14 | $28.67M 10-Q · filed 2022-11-14 | $29.47M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $2.22M 10-Q · filed 2022-08-15 | $3.31M 10-Q · filed 2022-08-15 | $4.11M derived: sum of 3 quarters · filed 2022-08-15 | $4.82M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.09M 10-Q · filed 2022-05-16 | $1.89M derived: sum of 2 quarters · filed 2022-05-16 | $2.60M derived: sum of 3 quarters · filed 2022-05-16 | $3.14M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $802.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.51M derived: sum of 2 quarters · filed 2022-03-30 | $2.05M derived: sum of 3 quarters · filed 2022-03-30 | $2.66M 10-K · filed 2022-03-30 |
| 2020-09-30 | $704.00K 10-Q · filed 2021-11-15 | $1.25M derived: sum of 2 quarters · filed 2021-11-15 | $1.86M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $541.00K 10-Q · filed 2021-09-13 | $1.15M 10-Q · filed 2021-09-13 |